Allergy Therapeutics plc (FRA:HHU)

Allergy Therapeutics Statistics

Total Valuation

FRA:HHU has a market cap or net worth of EUR 733.55 million. The enterprise value is 759.53 million.

Market Cap	733.55M
Enterprise Value	759.53M

Important Dates

The last earnings date was Thursday, November 20, 2025.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	6.14B
Shares Outstanding	n/a
Shares Change (YoY)	+180.43%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	3.45%
Float	1.70B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.90
PB Ratio	-84.84
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.62
EV / Sales	12.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.55

Financial Position

The company has a current ratio of 1.60

Current Ratio	1.60
Quick Ratio	1.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.39
Interest Coverage	-8.01

Financial Efficiency

Return on equity (ROE) is -369.20% and return on invested capital (ROIC) is -48.41%.

Return on Equity (ROE)	-369.20%
Return on Assets (ROA)	-25.11%
Return on Invested Capital (ROIC)	-48.41%
Return on Capital Employed (ROCE)	-61.31%
Revenue Per Employee	109,971
Profits Per Employee	-70,440
Employee Count	612
Asset Turnover	0.78
Inventory Turnover	2.15

Taxes

In the past 12 months, FRA:HHU has paid 45,951 in taxes.

Income Tax	45,951
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +69.36% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+69.36%
50-Day Moving Average	0.09
200-Day Moving Average	0.08
Relative Strength Index (RSI)	67.66
Average Volume (20 Days)	14,139

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:HHU had revenue of EUR 67.30 million and -43.11 million in losses. Loss per share was -0.01.

Revenue	67.30M
Gross Profit	36.37M
Operating Income	-34.51M
Pretax Income	-43.06M
Net Income	-43.11M
EBITDA	-32.10M
EBIT	-34.51M
Loss Per Share	-0.01

Balance Sheet

The company has 26.21 million in cash and 53.83 million in debt, giving a net cash position of -27.62 million.

Cash & Cash Equivalents	26.21M
Total Debt	53.83M
Net Cash	-27.62M
Net Cash Per Share	n/a
Equity (Book Value)	-8.65M
Book Value Per Share	-0.00
Working Capital	19.03M

Cash Flow

In the last 12 months, operating cash flow was -35.15 million and capital expenditures -3.70 million, giving a free cash flow of -38.85 million.

Operating Cash Flow	-35.15M
Capital Expenditures	-3.70M
Free Cash Flow	-38.85M
FCF Per Share	n/a

Margins

Gross margin is 54.04%, with operating and profit margins of -51.27% and -64.05%.

Gross Margin	54.04%
Operating Margin	-51.27%
Pretax Margin	-63.98%
Profit Margin	-64.05%
EBITDA Margin	-47.69%
EBIT Margin	-51.27%
FCF Margin	n/a

Dividends & Yields

FRA:HHU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-180.43%
Shareholder Yield	-180.43%
Earnings Yield	-5.88%
FCF Yield	-5.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:HHU has an Altman Z-Score of -2.78 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.78
Piotroski F-Score	2